The increasing prevalence of pelvic floor disorders has led to growing demand for non-surgical treatment options, making the vaginal pessary device an essential solution for millions of women worldwide. As healthcare providers increasingly recommend conservative therapies, the pelvic organ prolapse treatment market and stress urinary incontinence devices segment continue to expand, supporting the rapid evolution of the Pessary Market. Pessaries provide an effective, minimally invasive approach for managing pelvic organ prolapse (POP) and stress urinary incontinence (SUI), offering symptom relief while reducing the need for surgery. Growing awareness of women's pelvic health, advancements in device materials, and the rising geriatric female population are further accelerating market growth.

The global Pessary Market was valued at USD 412.2 million in 2024 and is projected to grow at a CAGR of 6.25% during 2025–2034. The market is estimated to reach USD 775.84 million in 2025 and USD 736.5 million by 2034.

Understanding the Role of Vaginal Pessary Devices

A vaginal pessary device is a removable medical device inserted into the vagina to provide structural support for pelvic organs that have shifted due to weakened pelvic floor muscles. Pessaries are commonly used to manage pelvic organ prolapse and stress urinary incontinence, particularly in women who wish to delay or avoid surgical intervention.

Available in various shapes and sizes—including ring, Gellhorn, cube, and donut pessaries—these devices are selected based on the severity of the condition, patient anatomy, and clinical requirements. Manufactured from biocompatible materials such as medical-grade silicone, modern pessaries are designed for long-term comfort, durability, and ease of maintenance.

Healthcare professionals often recommend pessaries for elderly women, postpartum patients, or individuals who are not suitable candidates for surgery because of age or underlying health conditions.

Growing Demand in the Pelvic Organ Prolapse Treatment Market

The expanding pelvic organ prolapse treatment market is a major driver of the global Pessary Market. Pelvic organ prolapse occurs when the muscles and connective tissues supporting pelvic organs weaken, causing organs such as the bladder, uterus, or rectum to descend into the vaginal canal.

Contributing factors include:

• Aging and menopause
• Multiple pregnancies and vaginal childbirth
• Obesity
• Chronic coughing
• Heavy lifting
• Connective tissue disorders

Although surgery remains an option for severe cases, many patients prefer conservative management using pessaries due to lower risks, reduced recovery time, and lower healthcare costs. As awareness of pelvic floor disorders improves, more women are seeking early diagnosis and non-invasive treatment options.

Stress Urinary Incontinence Devices Improving Quality of Life

The demand for stress urinary incontinence devices is increasing as urinary leakage becomes a common concern among aging women and postpartum patients. Stress urinary incontinence occurs when physical activities such as coughing, sneezing, laughing, or exercising place pressure on the bladder, resulting in involuntary urine leakage.

Pessaries specifically designed for stress urinary incontinence help reposition the urethra and bladder neck, improving urinary control without requiring medication or surgery.

Key benefits include:

• Immediate symptom relief
• Non-surgical treatment option
• Improved daily comfort and mobility
• Reduced healthcare costs
• Enhanced quality of life

As awareness campaigns and women's health initiatives continue to expand globally, demand for conservative urinary incontinence management is expected to grow significantly.

Factors Driving the Pessary Market

The global Pessary Market is experiencing steady growth due to several important factors:

• Rising prevalence of pelvic floor disorders
• Increasing aging female population
• Growing awareness of women's reproductive health
• Higher acceptance of minimally invasive treatments
• Improvements in pessary design and biocompatible materials
• Expanding access to gynecological healthcare services

In addition, healthcare providers are increasingly recommending pessaries as a first-line treatment before considering surgical intervention, particularly for patients with mild-to-moderate pelvic organ prolapse.

The growing emphasis on patient-centered care and cost-effective treatment options is expected to further strengthen market demand during the forecast period.

Discover the Complete Report Here:

https://www.polarismarketresearch.com/industry-analysis/pessary-market

Some of the major players operating in the global market include:

• Bioteque America
• Bliss GVS Pharma
• CooperSurgical Inc.
• Dr. Arabin GmbH & Co. KG
• Integra LifeSciences
• MedGyn
• Panpac Medical Corporation
• Personal Medical Corporation
• Wallach Surgical Devices

Regional Market Outlook

North America currently represents a significant share of the Pessary Market, supported by advanced healthcare infrastructure, widespread awareness of pelvic floor disorders, and strong access to gynecological services. Europe also maintains a substantial market presence due to increasing adoption of conservative treatment approaches and favorable reimbursement policies.

Meanwhile, the Asia-Pacific region is expected to witness the fastest growth during the forecast period. Rising healthcare expenditure, increasing awareness of women's health, expanding access to specialized gynecological care, and rapidly aging populations are creating significant opportunities for market expansion across countries such as China, India, and Japan.

Future Outlook

The future of the Pessary Market will be shaped by continuous innovation in biomaterials, personalized medical devices, and preventive women's healthcare. Increasing investment in pelvic health education and improvements in diagnostic services are expected to encourage earlier treatment and greater adoption of pessaries.

As healthcare systems continue to emphasize minimally invasive solutions and patient-centered care, pessaries are likely to remain a preferred treatment option for pelvic organ prolapse and stress urinary incontinence.

Conclusion

The growing use of the vaginal pessary device, expanding pelvic organ prolapse treatment market, and increasing demand for stress urinary incontinence devices are driving sustained growth in the Pessary Market. Supported by technological advancements, rising awareness of pelvic floor disorders, and a growing preference for non-surgical treatment options, the market is well positioned for continued expansion. As innovation continues to improve device performance and patient comfort, pessaries will remain an essential component of modern women's pelvic healthcare.

More Trending Latest Reports By Polaris Market Research:

Cancer Or Tumor Profiling Market

Medical Polyetheretherketone Market

US Medical Billing Outsourcing Market

High And Ultra-high-field Nuclear Magnetic Resonance Spectroscopy Market

Liver Disease Diagnostics Market

Cystatin C Assay Market

LATAM Gaucher Disease Treatment Market

Breast Conserving Surgery Market